Feeds › Patents
Patents
New US patents granted to public companies.
About this data
- What it is
- The US Patent and Trademark Office (USPTO) grants new patents every Tuesday. We match the companies named as owners to public companies.
- Who files it
- The USPTO publishes each grant.
- How current
- Grants are published every Tuesday, and we collect them weekly.
- Worth knowing
- A patent count says little about how valuable the patents are. We match owners to companies automatically, so a few may be missed.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Patents granted per week, last 12 weeks
Latest patent grants
Showing: ticker ARCT
| Granted | Patent | Owner | Type | Source |
|---|---|---|---|---|
| Nov 10, 2026 | 12788828 Nucleic acids and methods of treatment for cystic fibrosis | ARCT Arcturus Therapeutics Holdings Inc. | utility | Google Patents ↗ |
| Sep 1, 2026 | 12723023 Ionizable cationic lipids for RNA delivery | ARCT Arcturus Therapeutics Holdings Inc. | utility | Google Patents ↗ |
| May 26, 2026 | 12637422 Ionizable cationic lipid for RNA delivery | ARCT Arcturus Therapeutics Holdings Inc. | utility | Google Patents ↗ |
| Jan 27, 2026 | 12533410 Nucleic acid vaccine composition comprising a lipid formulation, and… | ARCT Arcturus Therapeutics Holdings Inc. | utility | Google Patents ↗ |
| Jan 20, 2026 | 12527881 Ionizable cationic lipid for RNA delivery | ARCT Arcturus Therapeutics Holdings Inc. | utility | Google Patents ↗ |
| Dec 30, 2025 | 12509698 Synthesis and structure of high potency RNA therapeutics | ARCT Arcturus Therapeutics Holdings Inc. | utility | Google Patents ↗ |
| Dec 2, 2025 | RE50681 Ionizable cationic lipid for RNA delivery | ARCT Arcturus Therapeutics Holdings Inc. | reissue | Google Patents ↗ |
| Aug 26, 2025 | 12398379 Compositions and methods for treating ornithine transcarbamylase defi… | ARCT Arcturus Therapeutics Holdings Inc. | utility | Google Patents ↗ |
| Aug 19, 2025 | 12390524 Compositions and methods for inducing immune responses | ARCT Arcturus Therapeutics Holdings Inc. | utility | Google Patents ↗ |
| Jul 8, 2025 | 12351834 Compositions and methods for the treatment of ornithine transcarbamyl… | ARCT Arcturus Therapeutics Holdings Inc. | utility | Google Patents ↗ |
| May 6, 2025 | 12290567 Asialoglycoprotein Receptor mediated delivery of therapeutically acti… | ARCT Arcturus Therapeutics Holdings Inc. | utility | Google Patents ↗ |
| Apr 29, 2025 | 12286395 Method of synthesis of an ionizable cationic lipid | ARCT Arcturus Therapeutics Holdings Inc. | utility | Google Patents ↗ |
| Feb 11, 2025 | 12220485 Method of making lipid-encapsulated RNA nanoparticles | ARCT Arcturus Therapeutics Holdings Inc. | utility | Google Patents ↗ |
| Feb 11, 2025 | 12220455 Coronavirus vaccine compositions and methods | ARCT Arcturus Therapeutics Holdings Inc. | utility | Google Patents ↗ |
| Jan 21, 2025 | 12202841 Therapeutic agents for enhancing epithelial and/or endothelial barrie… | ARCT Arcturus Therapeutics Holdings Inc. | utility | Google Patents ↗ |
| Dec 31, 2024 | 12178921 Method of lyophilizing lipid nanoparticles | ARCT Arcturus Therapeutics Holdings Inc. | utility | Google Patents ↗ |
16 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:34 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Clinical trial updates · FDA approvals and clearances